Literature DB >> 6381441

Upper airway closing pressures in snorers.

F G Issa, C E Sullivan.   

Abstract

We studied 14 subjects who were selected to represent the broad range of severity of snoring: group A, four subjects who gave a history of snoring only when provoked by nasal obstruction or alcohol intake; group B, six subjects who typically snored for long periods each night; and group C, four subjects who snored heavily all night and who typically experienced a few episodes of obstructive apnea (mean apnea index 4 apneas/h). Low levels of nasal continuous positive airway pressure (CPAP) (range, 2.0-6.0 cmH2O; mean, 4.0 cmH2O) prevented snoring. Nasal occlusion caused upper airway closure during inspiratory efforts in all 14 subjects. There was a relationship between the clinical severity of snoring and the upper airway closing pressure (UACP). Upper airway closure occurred at greater suction pressures in group A than in group C but there was overlap between the three categories. The upper airway was consistently more collapsible in rapid-eye-movement sleep than in non-rapid-eye-movement sleep. There was little evidence of breath-by-breath improvement of upper airway stability during sustained asphyxia, the UACP remaining constant despite marked increases in drive to the diaphragm. In five subjects UACP was measured following alcohol intake. Alcohol reduced upper airway stability in all subjects in a dose-dependent manner.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381441     DOI: 10.1152/jappl.1984.57.2.528

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  15 in total

1.  Cigarette smoking behavior and respiratory alterations during sleep in a healthy population.

Authors:  Gonzalo G Casasola; José L Alvarez-Sala; José A Marques; José M F Sánchez-Alarcos; Donald P Tashkin; Domingo Espinós
Journal:  Sleep Breath       Date:  2002-03       Impact factor: 2.816

Review 2.  Mechanisms of vascular damage in obstructive sleep apnea.

Authors:  Malcolm Kohler; John R Stradling
Journal:  Nat Rev Cardiol       Date:  2010-12       Impact factor: 32.419

Review 3.  Phenotyping the pathophysiology of obstructive sleep apnea using polygraphy/polysomnography: a review of the literature.

Authors:  Marcello Bosi; Andrea De Vito; Bhik Kotecha; Luca Viglietta; Alberto Braghiroli; Joerg Steier; Martino Pengo; Giovanni Sorrenti; Riccardo Gobbi; Claudio Vicini; Venerino Poletti
Journal:  Sleep Breath       Date:  2018-01-09       Impact factor: 2.816

4.  The impact of anatomic manipulations on pharyngeal collapse: results from a computational model of the normal human upper airway.

Authors:  Yaqi Huang; David P White; Atul Malhotra
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

5.  Association Between Benzodiazepine Receptor Agonists and Snoring Among Women in the Nurses' Health Study.

Authors:  Brian M Lin; Frank B Hu; Gary C Curhan
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-02-01       Impact factor: 6.223

6.  [Mechanisms of supralaryngeal airway obstruction in normal persons and habitual mouth breathers].

Authors:  W Chowanetz; J Schott; B Jany
Journal:  Klin Wochenschr       Date:  1987-03-16

7.  Bedtime ethanol increases resistance of upper airways and produces sleep apneas in asymptomatic snorers.

Authors:  M M Mitler; A Dawson; S J Henriksen; M Sobers; F E Bloom
Journal:  Alcohol Clin Exp Res       Date:  1988-12       Impact factor: 3.455

Review 8.  Acoustic reflection: review and clinical applications for sleep-disordered breathing.

Authors:  John S Viviano
Journal:  Sleep Breath       Date:  2002-09       Impact factor: 2.816

9.  Effect of bedtime ethanol on total inspiratory resistance and respiratory drive in normal nonsnoring men.

Authors:  A Dawson; P Lehr; B G Bigby; M M Mitler
Journal:  Alcohol Clin Exp Res       Date:  1993-04       Impact factor: 3.455

10.  The influence of nocturnal alcohol ingestion on snoring.

Authors:  Randolf Riemann; Ralf Volk; Alexander Müller; Michael Herzog
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.